Pharmaceutical

NICE recommends Boehringer’s tenecteplase for NHS stroke care

The UK NICE has issued final guidance endorsing Boehringer Ingelheim’s tenecteplase for acute ischaemic stroke for NHS use.

Jul 26, 2024 - 04:00
NICE recommends Boehringer’s tenecteplase for NHS stroke care
The UK NICE has issued final guidance endorsing Boehringer Ingelheim’s tenecteplase for acute ischaemic stroke for NHS use.
Read the original article

Tags:

Previous Article

FDA agrees wider use of BioMarin’s BRINEURA for CLN2

Next Article

Dren Bio and Novartis link on bispecific antibodies for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novartis and Versant launch Borealis Biosciences with $150m

Novartis and Versant launch Borealis Biosciences with $...

Aug 23, 2024

A disabled artist’s journey from ‘Oh, sorry’ to social justice activism

A disabled artist’s journey from ‘Oh, sorry’ to social ...

Mar 8, 2024

Lyra Therapeutics gets grant for coated scaffold for tr...

Aug 23, 2024